News & Updates

Treatment with fixed-dose asthma inhaler combination of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) helps improve lung function and reduce exacerbations as compared with MF/IND and fluticasone/salmeterol (FLU/SAL), regardless of baseline eosinophil levels, according to a post hoc analysis of the IRIDIUM study.

Subsequent pregnancies (SSPs) may lead to adverse outcomes in women with peripartum cardiomyopathy (PPCM), reveals a study, noting that the normalization of left ventricular function is not an assurance for a positive outcome in SSPs.

Jaktinib, a novel JAK and AVCR1 inhibitor, is more effective than hydroxyurea in patients with myelofibrosis, resulting in better spleen response with improved symptom response and less cytopenias, according to the results of a phase III study presented at EHA 2023.

Outcomes are significantly worse in patients diagnosed with type 2 myocardial infarction (MI) with objective evidence of myocardial ischaemia compared with those with myocardial injury and subjective type 2 MI, reports a study.

A technology-enabled virtual ward may be a feasible alternative to hospitalization for high-risk COVID-19 patients such as the elderly and the immunocompromised, a retrospective cohort study from Singapore suggests.

In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.